Viewing Study NCT07025369


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-01-02 @ 8:00 AM
Study NCT ID: NCT07025369
Status: RECRUITING
Last Update Posted: 2025-09-11
First Post: 2025-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Adenocarcinoma View
None Stage IIC Prostate Cancer AJCC v8 View
None Stage III Prostate Cancer AJCC v8 View
None Stage IV Prostate Cancer AJCC v8 View
Keywords: